These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3220320)

  • 1. Immunoradiometric studies with a monoclonal antibody against an estrogen-receptor-related protein in human breast cancer.
    Cano A; Rivera J; Parrilla JJ; Abad L
    Gynecol Obstet Invest; 1988; 26(2):166-70. PubMed ID: 3220320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p29 protein in breast cancer: relation between estrogen and progesterone receptors.
    Artero Morà A; Lluch Hernandez A; Cano Sanchez A; Bueno Cañigral FJ; Martin Quetglas G; Alberola Candel V; Garcia-Conde Bru J
    Tumori; 1989 Apr; 75(2):113-6. PubMed ID: 2741216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histochemical studies with an estrogen receptor-related protein in human breast tumors.
    Cano A; Coffer AI; Adatia R; Millis RR; Rubens RD; King RJ
    Cancer Res; 1986 Dec; 46(12 Pt 1):6475-80. PubMed ID: 3536082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Estrogen and progestogen cytosol receptors in human breast carcinoma (author's transl)].
    May-Levin F; Guerinot F; Contesso G; Delarue JC; Bohuon C
    Int J Cancer; 1977 Jun; 19(6):789-95. PubMed ID: 873643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstration of P29, an oestrogen receptor-associated tumor marker, in human term placenta.
    Cano A; Rivera J
    Placenta; 1991; 12(2):153-60. PubMed ID: 1908078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of p29, an estrogen-receptor associated tumor marker.
    Coffer AI; King RJ
    J Steroid Biochem; 1988 Nov; 31(5):745-50. PubMed ID: 3199814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and biological relevance of a 29-kDa, oestrogen receptor-related protein.
    King RJ; Finley JR; Coffer AI; Millis RR; Rubens RD
    J Steroid Biochem; 1987; 27(1-3):471-5. PubMed ID: 3695491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of estradiol and progesterone receptors in early and advanced breast tumors.
    King RJ
    Cancer; 1980 Dec; 46(12 Suppl):2818-21. PubMed ID: 7448727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical applications of receptor measurements in breast cancer.
    Holdaway IM; Mountjoy KG; Harvey VJ; Allen EP; Stephens EJ
    Br J Cancer; 1980 Jan; 41(1):136-9. PubMed ID: 7362774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptionally active non-ligand binding oestrogen receptors in breast cancer.
    Marsigliante S; Greco S; Biscozzo L; Barker S; Baker V; Giuseppe L; Vinson GP; Storelli C
    Cancer Lett; 1992 Oct; 66(3):183-91. PubMed ID: 1451100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological evidence for the identity between the hsp27 estrogen-regulated heat shock protein and the p29 estrogen receptor-associated protein in breast and endometrial cancer.
    Ciocca DR; Luque EH
    Breast Cancer Res Treat; 1991 Dec; 20(1):33-42. PubMed ID: 1667487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer.
    Clark GM; Osborne CK; McGuire WL
    J Clin Oncol; 1984 Oct; 2(10):1102-9. PubMed ID: 6491696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic value of estradiol and progesterone receptors in stage I and II breast cancer with an adjuvant treatment].
    Bolla M; Bonnabel P; Chedin M; Villemain D; Zins M; Mousseau M; Chambaz E
    Bull Cancer; 1987; 74(6):623-30. PubMed ID: 3435786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoradiometric studies with monoclonal antibody against a component related to human estrogen receptor.
    Coffer AI; Spiller GH; Lewis KM; King RJ
    Cancer Res; 1985 Aug; 45(8):3694-8. PubMed ID: 4016747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Factors affecting estrogen and progesterone receptors in primary breast cancer].
    Kuno K; Fukami A; Hori M; Kasumi F; Yoshimoto K
    Gan No Rinsho; 1983 May; 29(6):621-7. PubMed ID: 6876431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
    Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological probes for oestradiol receptors in human breast tumours.
    King RJ; Cano A; Finley J; Coffer AI
    J Steroid Biochem; 1986 Jan; 24(1):369-72. PubMed ID: 3517498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
    Berger U; Wilson P; Thethi S; McClelland RA; Greene GL; Coombes RC
    Cancer Res; 1989 Sep; 49(18):5176-9. PubMed ID: 2766287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The incidence of positive oestrogen and progesterone receptors in breast cancer of Greek women.
    Vassilaros S; Adamopoulos DA; Papadiamantis J; Dessypris A; Kapolla N
    Anticancer Res; 1981; 1(4):195-7. PubMed ID: 7345966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic value of estrogen and progesterone receptors in the operable breast cancer: results of a uni- and multifactorial analysis].
    Chevallier B; Heintzman F; Asselain B; Dauce JP; Bastit P; Graic Y; Brunelle P; Basuyau JP; Comoz M
    Bull Cancer; 1988; 75(1):23-36. PubMed ID: 3359056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.